Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fortive Corp Director's Dealing 2020

Nov 18, 2020

30364_dirs_2020-11-17_dd05a096-5ecb-4407-a66a-c5f02d3f2a71.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fortive Corp (FTV)
CIK: 0001659166
Period of Report: 2020-11-16

Reporting Person: Pringle William W (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-16 Common Stock M 17848 $24.75 Acquired 89226 Direct
2020-11-16 Common Stock M 16246 $27.26 Acquired 105472 Direct
2020-11-16 Common Stock M 16443 $31.07 Acquired 121915 Direct
2020-11-16 Common Stock M 16739 $30.42 Acquired 138654 Direct
2020-11-16 Common Stock M 19672 $35.31 Acquired 158326 Direct
2020-11-16 Common Stock S 56428 $71.05 Disposed 101898 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-16 Employee Stock Option (Right to Buy) $24.75 M 17848 Disposed 2023-02-21 Common Stock (17848.0) Direct
2020-11-16 Employee Stock Option (Right to Buy) $27.26 M 16246 Disposed 2023-07-30 Common Stock (16246.0) Direct
2020-11-16 Employee Stock Option (Right to Buy) $31.07 M 16443 Disposed 2024-02-24 Common Stock (16443.0) Direct
2020-11-16 Employee Stock Option (Right to Buy) $30.42 M 16739 Disposed 2024-05-15 Common Stock (16739.0) Direct
2020-11-16 Employee Stock Option (Right to Buy) $35.31 M 19672 Disposed 2025-02-24 Common Stock (19672.0) Direct

Footnotes

F1: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.830 to $71.250. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F2: Prior to the separation of the Issuer from Danaher Corporation ("Danaher") on July 2, 2016 (the "Separation"), one-fifth of the stock options issued by Danaher on February 21, 2013 ("February 2013 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the February 2013 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 14,839 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020.

F3: Prior to the Separation, one-fifth of the stock options issued by Danaher on July 30, 2013 ("July 2013 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the July 2013 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 13,507 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020.

F4: Prior to the Separation, one-fifth of the stock options issued by Danaher on February 24, 2014 ("February 2014 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the February 2014 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 13,671 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020.

F5: Prior to the Separation, one-fifth of the stock options issued by Danaher on May 15, 2014 ("May 2014 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the May 2014 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 13,971 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020.

F6: Prior to the Separation, one-fifth of the stock options issued by Danaher on February 24, 2015 ("2015 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the 2015 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 16,356 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020.